4.00
2.56%
+0.09
전일 마감가:
$3.91
열려 있는:
$3.95
하루 거래량:
620.46K
시가총액:
$111.88M
수익:
-
순이익/손실:
$-54.19M
주가수익비율:
-1.3318
EPS:
-3.0035
순현금흐름:
$-37.34M
1주 성능:
+25.71%
1개월 성능:
-46.39%
6개월 성능:
+1.26%
1년 성능:
+22.26%
Abeona Therapeutics Inc Stock (ABEO) Company Profile
명칭
Abeona Therapeutics Inc
전화
646 813 4701
주소
1330 Avenue of the Americas, 33rd Floor, New York, NY
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2020-11-11 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2020-09-18 | 개시 | B. Riley FBR | Buy |
2020-02-10 | 개시 | SVB Leerink | Outperform |
2019-12-10 | 재개 | Cantor Fitzgerald | Neutral |
2019-08-15 | 다운그레이드 | Maxim Group | Buy → Hold |
2019-08-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2019-07-26 | 다운그레이드 | Mizuho | Buy → Neutral |
2019-06-27 | 개시 | Mizuho | Buy |
2018-10-12 | 개시 | Mizuho | Buy |
2018-06-05 | 개시 | Seaport Global Securities | Buy |
2017-11-08 | 개시 | SunTrust | Buy |
2017-10-16 | 재확인 | H.C. Wainwright | Buy |
2017-10-11 | 재확인 | Cantor Fitzgerald | Overweight |
2017-10-10 | 개시 | Citigroup | Buy |
2017-10-05 | 재확인 | Maxim Group | Buy |
2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
2017-07-18 | 재확인 | Maxim Group | Buy |
2017-06-22 | 재개 | Jefferies | Buy |
2017-01-06 | 개시 | Jefferies | Buy |
2016-09-29 | 재확인 | Maxim Group | Buy |
모두보기
Abeona Therapeutics Inc 주식(ABEO)의 최신 뉴스
Abeona Therapeutics Provides Regulatory Update on Pz-cel
GlobeNewswire Inc.
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
GlobeNewswire Inc.
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
Benzinga
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Abeona Therapeutics Inc (ABEO) 재무 분석
Abeona Therapeutics Inc (ABEO) 순이익 2024
ABEO은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -54.19M 달러로 보고했으며, 전년대비 -36.51% 감소했습니다.
Abeona Therapeutics Inc (ABEO) 현금흐름 2024
2023-12-31 종료 분기에 ABEO은 현금흐름(지난 12개월)으로 -37.34M 달러를 기록했으며, 전년 대비 +14.38% 증가했습니다.
Abeona Therapeutics Inc (ABEO) 주당 순이익 2024
ABEO이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -2.58달러이며, 전년 대비 +60.68% 성장했습니다.
Abeona Therapeutics Inc 주식 (ABEO) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Seshadri Vishwas | Chief Executive Officer |
Apr 25 '24 |
Buy |
3.20 |
10,000 |
32,000 |
538,260 |
O'Malley Brendan M. | SVP, General Counsel |
Apr 25 '24 |
Buy |
3.24 |
8,600 |
27,864 |
188,718 |
Vazzano Joseph Walter | Chief Financial Officer |
Apr 25 '24 |
Buy |
3.14 |
5,608 |
17,609 |
233,868 |
Seshadri Vishwas | Chief Executive Officer |
Feb 06 '24 |
Buy |
4.39 |
20,000 |
87,800 |
528,260 |
Alvino Mark | Director |
Jan 17 '24 |
Sale |
5.11 |
7,084 |
36,199 |
62,816 |
Seshadri Vishwas | Chief Executive Officer |
Sep 27 '23 |
Buy |
4.07 |
20,000 |
81,400 |
521,731 |
Charles Faith L. | Director |
Sep 27 '23 |
Sale |
4.91 |
8,330 |
40,924 |
70,773 |
Alland Leila | Director |
Sep 27 '23 |
Sale |
3.90 |
7,246 |
28,270 |
71,857 |
Alvino Mark | Director |
Sep 27 '23 |
Sale |
3.91 |
6,316 |
24,724 |
69,900 |
Silverstein Christine Berni | Director |
Sep 27 '23 |
Sale |
3.91 |
6,330 |
24,721 |
87,884 |
자본화:
|
볼륨(24시간):